Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | KLK7 | P49862 | 2/20 | 0.57 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.57 |
| ▸ | SIRT5 | Q9NXA8 | 2/20 | 0.55 |
| ▸ | SIRT2 | Q8IXJ6 | 6/20 | 0.55 |
| ▸ | SIRT1 | Q96EB6 | 5/20 | 0.55 |
| ▸ | SIRT3 | Q9NTG7 | 3/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13599684 | 0.95 | MAPT (0.57) | L3MBTL1MAPTKLK7KLK5SIRT5 | |
| SCHEMBL29813489 | 0.94 | MAPT (0.56) | MAPTKLK7KLK5SIRT5SIRT2 | |
| SCHEMBL30064541 | 0.93 | MAPT (0.62) | L3MBTL1MAPTKLK7KLK5 | |
| SCHEMBL17039826 | 0.91 | FOLH1 (0.60) | MAPTKLK7KLK5SIRT5SIRT2 | |
| SCHEMBL27497192 | 0.91 | KLK7 (0.63) | MAPTKLK7KLK5SIRT2SIRT1 | |
| SCHEMBL30544856 | 0.91 | KLK7 (0.63) | MAPTKLK7KLK5SIRT2SIRT1 | |
| SCHEMBL30668140 | 0.90 | KLK7 (0.57) | L3MBTL1MAPTKLK7KLK5 | |
| SCHEMBL28589406 | 0.90 | KLK7 (0.60) | MAPTKLK7KLK5 | |
| SCHEMBL2291347 | 0.90 | KLK7 (0.60) | MAPTKLK7KLK5 | |
| SCHEMBL30902797 | 0.90 | MAPT (0.62) | MAPTKLK7KLK5SIRT5SIRT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090311203-A1 | GEM-DIFLUORIDE C-GLYCOPEPTIDE COMPOUNDS, THEIR PREPARATION AND USE PARTICULARLY FOR PRESERVATION OF BIOLOGICAL MATERIALS | INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE ROUEN (INSA) (FR) | 2009-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090311203-A1 | GEM-DIFLUORIDE C-GLYCOPEPTIDE COMPOUNDS, THEIR PREPARATION AND USE PARTICULARLY FOR PRESERVATION OF BIOLOGICAL MATERIALS | B3GAT3, GMFG, GYPA | L3MBTL1 592/4885MAPT 3774/4885KLK7 4383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.